Radiology, Vol 204, 47-54, Copyright © 1997 by Radiological Society of North America

ARTICLES

Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance

A Taylor Jr, A Manatunga, K Morton, L Reese, FS Prato, E Greenberg, R Folks, BJ Kemp, ME Jones, PE Corrigan, J Galt and L Eshima
Department of Radiology, Emory University School of Medicine, Atlanta, GA 30322, USA.

PURPOSE: To evaluate an improved camera-based method for calculating the clearance of technetium-99m mercaptoacetyltriglycine (MAG3) in a multicenter trial. MATERIALS AND METHODS: Tc-99m MAG3 scintigraphy was performed in 49 patients at three sites in the United States and Canada. The percentage of the injected dose of Tc-99m MAG3 in the kidney at 1-2, 1.0-2.5, and 2-3 minutes after injection was correlated with the plasma-based Tc-99m MAG3 clearances. The data were combined with the results obtained in 20 additional patients in a previously published pilot study. RESULTS: Regression models correlating the plasma-based Tc-99m MAG3 clearance with the percentage uptake in the kidney for each time interval were developed; there was no statistically significant difference among sites in the regression equations. Correction for body surface area statistically significantly (P < .005) improved the correlation coefficient for each time interval. For the 1.0-2.5-minute interval, the body surface area-corrected correlation coefficient for the four combined sites was .87, and it improved to .93 when one outlier was omitted from the analysis. Similar results were obtained with the other time intervals. Independent processing by two observers showed no clinically important differences in the percentage dose in the kidney or in relative function. CONCLUSION: An improved camera-based method to calculate the clearance of Tc-99m MAG3 was validated in a multicenter trial.

This article has been cited by other articles:

				A. Taylor, E. V. Garcia, J. N. G. Binongo, A. Manatunga, R. Halkar, R. D. Folks, and E. Dubovsky Diagnostic Performance of an Expert System for Interpretation of 99mTc MAG3 Scans in Suspected Renal Obstruction J. Nucl. Med., February 1, 2008; 49(2): 216 - 224. [Abstract] [Full Text] [PDF]

				A. Taylor, A. N. Hill, J. N. E. Binongo, A. K. Manatunga, R. Halkar, E. V. Dubovsky, and E. V. Garcia Evaluation of Two Diuresis Renography Decision Support Systems to Determine the Need for Furosemide in Patients with Suspected Obstruction Am. J. Roentgenol., May 1, 2007; 188(5): 1395 - 1402. [Abstract] [Full Text] [PDF]

				R. D. Folks, E. V. Garcia, and A. T. Taylor Development and Prospective Evaluation of an Automated Software System for Quality Control of Quantitative 99mTc-MAG3 Renal Studies J. Nucl. Med. Technol., March 1, 2007; 35(1): 27 - 33. [Abstract] [Full Text] [PDF]

				E. V. Garcia, A. Taylor, D. Manatunga, and R. Folks A Software Engine to Justify the Conclusions of an Expert System for Detecting Renal Obstruction on 99mTc-MAG3 Scans J. Nucl. Med., March 1, 2007; 48(3): 463 - 470. [Abstract] [Full Text] [PDF]

				F. P. Esteves, A. Taylor, A. Manatunga, R. D. Folks, M. Krishnan, and E. V. Garcia 99mTc-MAG3 Renography: Normal Values for MAG3 Clearance and Curve Parameters, Excretory Parameters, and Residual Urine Volume. Am. J. Roentgenol., December 1, 2006; 187(6): W610 - W617. [Abstract] [Full Text] [PDF]

				F. P. Esteves, R. K. Halkar, M. M. Issa, S. Grant, and A. Taylor Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function. Am. J. Roentgenol., September 1, 2006; 187(3): W316 - W319. [Abstract] [Full Text] [PDF]

				E. V. Garcia, A. Taylor, R. Halkar, R. Folks, M. Krishnan, C. D. Cooke, and E. Dubovsky RENEX: An Expert System for the Interpretation of 99mTc-MAG3 Scans to Detect Renal Obstruction J. Nucl. Med., February 1, 2006; 47(2): 320 - 329. [Abstract] [Full Text] [PDF]

				Y. Inoue, K. Yoshikawa, N. Yoshioka, T. Watanabe, S. Saegusa, Y. Kaneko, I. Yokoyama, and K. Ohtomo Evaluation of Renal Function with 99mTc-MAG3 Using Semiautomated Regions of Interest J. Nucl. Med., December 1, 2000; 41(12): 1947 - 1954. [Abstract] [Full Text] [PDF]